CRISPR THERAPEUTICS AG (CRSP)

SEC filing

CRISPR THERAPEUTICS AG

CRSP · CIK 1674416

4 · Sep 21, 2026 · Director Behbahani Ali sold 13.68K Common Shares at $57.09/unit ($780.9K); exercised options for 60K shares

Director Behbahani Ali sold 13.68K Common Shares at $57.09/unit ($780.9K); exercised options for 60K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).